The company has received approval from the US Food and Drug
Administration (USFDA) to market its product, which is a generic
version of Anacor Pharmaceuticals' Kerydin Topical Solution, Lupin
said in a statement.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-gets-usfda-to-market-generic-anti-fungal-cream-in-us-market/articleshow/80768873.cms
No comments:
Post a Comment